BIVIWNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$2.535 M
$0.30 +1.70%
Close of 22 Sept 2026
Revenue
—
Not reported
Earnings
-$17.5M
Loss-making
Shares outstanding
7,542,638
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Biovie lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Biovie are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.